华邦健康
(002004)
| 流通市值：72.65亿 | | | 总市值：76.42亿 |
| 流通股本：18.82亿 | | | 总股本：19.80亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,639,754,636.68 | 3,869,597,463.56 | 4,112,423,354.67 | 3,782,850,563.11 |
| 应收票据及应收账款 | 2,574,723,692.63 | 2,368,083,378.54 | 2,099,143,643.33 | 1,650,398,554.46 |
| 其中：应收票据 | 208,760,750.61 | 196,802,156.6 | 151,963,883.09 | 147,994,276.75 |
| 应收账款 | 2,365,962,942.02 | 2,171,281,221.94 | 1,947,179,760.24 | 1,502,404,277.71 |
| 应收款项融资 | 274,899,906.38 | 263,774,691.79 | 343,513,198.37 | 387,256,072.91 |
| 预付款项 | 175,703,413.53 | 139,465,990.4 | 131,846,841.49 | 115,982,366.59 |
| 其他应收款合计 | 701,917,565.15 | 775,905,968.66 | 693,974,919.99 | 681,226,452.81 |
| 其中:应收利息 | 6,800,187.74 | 8,017,919.83 | 8,516,782.83 | 6,874,073.88 |
| 应收股利 | - | 18,950,000 | - | - |
| 存货 | 2,363,782,001.1 | 2,490,337,051 | 2,507,214,008.25 | 2,674,605,594.89 |
| 合同资产 | 11,582,640.75 | 10,013,007.19 | 8,879,881.21 | 9,885,040.33 |
| 一年内到期的非流动资产 | 1,293,569.86 | 1,314,803.19 | 1,293,569.86 | 1,293,569.86 |
| 其他流动资产 | 1,449,194,973.92 | 1,326,564,124.71 | 1,462,627,629.32 | 1,453,616,669.9 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 11,788,700,071.67 | 11,774,867,639.42 | 12,150,426,262.96 | 11,387,399,700.74 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,556,028,978.4 | 2,640,624,861.39 | 2,739,944,094.04 | 2,755,101,118.86 |
| 其他权益工具投资 | 127,022,523.73 | 127,164,031.38 | 127,412,557.14 | 128,230,471.13 |
| 其他非流动金融资产 | 434,924.67 | 434,924.67 | 434,924.67 | 434,924.67 |
| 投资性房地产 | 856,011,285.43 | 862,989,961.91 | 755,628,999.45 | 743,676,276.45 |
| 固定资产 | 7,586,021,516.49 | 7,494,672,960.21 | 7,641,253,577.9 | 7,726,715,789.88 |
| 在建工程 | 2,065,290,590.32 | 2,140,930,928.51 | 1,961,267,635.97 | 1,869,334,952.2 |
| 生产性生物资产 | 26,451,292.95 | 26,649,903.62 | 26,910,785.55 | 27,184,697.44 |
| 使用权资产 | 410,293,442.88 | 416,674,893.01 | 423,011,055.12 | 428,419,946.81 |
| 无形资产 | 1,543,564,971.16 | 1,561,633,058.49 | 1,576,147,027.47 | 1,598,882,714.58 |
| 开发支出 | 80,016,653.11 | 72,905,642.05 | 61,867,545.42 | 53,557,958.73 |
| 商誉 | 2,739,933,395.2 | 2,739,933,395.2 | 2,739,933,395.2 | 2,739,933,395.2 |
| 长期待摊费用 | 498,745,693.02 | 503,648,321.78 | 525,183,512.2 | 486,972,722.7 |
| 递延所得税资产 | 513,874,829.54 | 498,389,328.01 | 462,184,017.76 | 434,037,993.45 |
| 其他非流动资产 | 270,264,688.04 | 271,455,101.2 | 287,438,701.19 | 347,513,897.51 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 19,273,954,784.94 | 19,358,107,311.43 | 19,328,617,829.08 | 19,339,996,859.61 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 31,062,654,856.61 | 31,132,974,950.85 | 31,479,044,092.04 | 30,727,396,560.35 |
| 流动负债: | | | | |
| 短期借款 | 4,018,256,650.3 | 4,846,563,618.95 | 5,401,268,916.43 | 4,665,538,537.05 |
| 交易性金融负债 | 586,961.84 | 610,946.58 | 171,985.04 | - |
| 应付票据及应付账款 | 2,312,245,531.28 | 2,256,524,042.83 | 2,303,004,419.85 | 2,702,851,009.09 |
| 其中：应付票据 | 834,701,431.98 | 715,943,116.06 | 890,946,647.12 | 1,199,065,204.03 |
| 应付账款 | 1,477,544,099.3 | 1,540,580,926.77 | 1,412,057,772.73 | 1,503,785,805.06 |
| 预收款项 | 11,951,561.82 | 9,325,800.49 | 9,071,717.61 | 12,700,677.8 |
| 合同负债 | 169,521,623.9 | 110,812,597.77 | 143,928,116.33 | 201,391,842.34 |
| 应付职工薪酬 | 182,845,037.16 | 154,240,951.86 | 188,672,387.95 | 350,159,481.71 |
| 应交税费 | 268,836,426.29 | 228,466,266.1 | 207,094,223.38 | 176,955,424.94 |
| 其他应付款合计 | 1,706,212,614.55 | 1,752,484,568.23 | 1,617,824,332.01 | 1,478,948,628.76 |
| 应付股利 | 2,008,330.82 | 71,850,939.02 | 2,172,159.82 | 2,388,943.82 |
| 一年内到期的非流动负债 | 1,901,537,449.92 | 1,878,177,652.29 | 1,392,885,724.82 | 1,028,216,931.93 |
| 其他流动负债 | 16,364,296.53 | 11,691,298.76 | 14,260,119.73 | 16,989,195.92 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 10,588,358,153.59 | 11,248,897,743.86 | 11,278,181,943.15 | 10,633,751,729.54 |
| 非流动负债: | | | | |
| 长期借款 | 2,913,200,189.33 | 2,619,464,820.98 | 2,536,729,807.97 | 2,621,012,948.99 |
| 应付债券 | 505,672,675.16 | 376,947,887.07 | 267,838,530.14 | 263,455,922.42 |
| 租赁负债 | 50,407,596.3 | 50,271,969.7 | 50,886,772.31 | 47,620,110.98 |
| 长期应付款 | 193,864,881.07 | 193,944,917.07 | 193,922,207.07 | 193,945,697.07 |
| 递延收益 | 250,645,314.49 | 261,772,939.9 | 265,119,243.95 | 271,232,653.86 |
| 递延所得税负债 | 105,972,419.84 | 109,272,421.63 | 108,389,904.5 | 111,644,305.4 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 4,019,763,076.19 | 3,611,674,956.35 | 3,422,886,465.94 | 3,508,911,638.72 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 14,608,121,229.78 | 14,860,572,700.21 | 14,701,068,409.09 | 14,142,663,368.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,979,919,191 | 1,979,919,191 | 1,979,919,191 | 1,979,919,191 |
| 资本公积 | 5,336,511,950.47 | 5,313,547,712.3 | 5,291,430,107.33 | 5,290,271,969.59 |
| 减:库存股 | 29,499,256.13 | 24,966,124.13 | 15,585,611.15 | - |
| 其他综合收益 | -134,346,359.35 | -116,572,990.56 | -105,279,045.23 | -101,286,628.03 |
| 专项储备 | 19,642,152.96 | 17,020,808.01 | 16,820,642.89 | 16,340,384.49 |
| 盈余公积 | 583,150,555.63 | 583,150,555.63 | 583,150,555.63 | 583,150,555.63 |
| 未分配利润 | 2,353,494,940.4 | 2,215,085,422.52 | 2,491,933,527.61 | 2,336,781,127.89 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 10,108,873,174.98 | 9,967,184,574.77 | 10,242,389,368.08 | 10,105,176,600.57 |
| 少数股东权益 | 6,345,660,451.85 | 6,305,217,675.87 | 6,535,586,314.87 | 6,479,556,591.52 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 16,454,533,626.83 | 16,272,402,250.64 | 16,777,975,682.95 | 16,584,733,192.09 |
| 负债和股东权益合计 | 31,062,654,856.61 | 31,132,974,950.85 | 31,479,044,092.04 | 30,727,396,560.35 |
| 公告日期 | 2024-10-29 | 2024-08-31 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |